Compare AstraZeneca plc (AZN) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Toronto-Dominion Bank — how do they compare? AstraZeneca plc trades at $157.96 (market cap $248.14B), while Toronto-Dominion Bank trades at $121.35 (market cap $200.48B). The key difference: AstraZeneca plc is the larger of the two by market cap, and Toronto-Dominion Bank pays the higher dividend (2.63%). Which is the better fit depends on your goals.
| AZN | TD | |
|---|---|---|
Market Cap | $248.14B | $200.48B |
Sector | Health | Financials |
52-Week High | $209.48 | $124.80 |
52-Week Low | $147.06 | $72.85 |
Enterprise Value | $275.41B | — |
Dividend Yield | 2.01% | 2.63% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
